Life Sciences Focus Xeraya Capital is a dedicated life sciences investor with a clear emphasis on funding and nurturing portfolio companies that aim to benefit humanity, presenting opportunities to position solutions that align with impact-driven investments and strategic partnerships within the life sciences ecosystem.

Global Bio Deals Recent investments span from the US to the UK and Malaysia, including rapid microbial detection, genomic data analysis, and digital health, indicating appetite for diverse biopharma, diagnostics, and health tech opportunities that can complement Xeraya’s portfolio.

Growth Equity Xeraya participates in mid to large equity rounds (tens of millions) and co-leads or leads significant Series B/C rounds, suggesting a target profile for scalable, early-to-mid stage companies seeking strategic capital and value-adding partnerships.

Regional Focus While active globally, Xeraya notes benefits to Malaysia and the surrounding region, signaling potential preference for regionally relevant solutions, market access support, and regulatory navigation assistance within Southeast Asia.

Portfolio Synergy With a track record of backing rapid diagnostics, genomic analytics, and biopharma manufacturing technologies, there are cross-sell and co-investment opportunities through shared technology platforms, distribution channels, and clinical/commercial collaboration across portfolio companies.